VitaSpring Biomedical VSBC Stock
1 USD
{{ price }}
0.000000%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
OTC Markets EXMKT
Market Cap
3.1B USD
LOW - HIGH [24H]
1
-
1 USD
VOLUME [24H]
100 USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD
VitaSpring Biomedical Price Chart
VitaSpring Biomedical VSBC Financial and Trading Overview
| VitaSpring Biomedical stock price | 1 USD |
| Previous Close | 16 USD |
| Open | 13.1 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 16 - 16 USD |
| 52 Week Range | 10 - 16.5 USD |
| Volume | 1 USD |
| Avg. Volume | 92 USD |
| Market Cap | 3.3B USD |
| Beta (5Y Monthly) | 1.410454 |
| PE Ratio (TTM) | Infinity |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
VSBC Valuation Measures
| Enterprise Value | 3.3B USD |
| Trailing P/E | Infinity |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 663.6513 |
| Price/Book (mrq) | 1999.9999 |
| Enterprise Value/Revenue | 663.713 |
| Enterprise Value/EBITDA | 2774.451 |
Trading Information
VitaSpring Biomedical Stock Price History
| Beta (5Y Monthly) | 1.410454 |
| 52-Week Change | 6.66% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 16.5 USD |
| 52 Week Low | 10 USD |
| 50-Day Moving Average | 15.13 USD |
| 200-Day Moving Average | 14.85 USD |
VSBC Share Statistics
| Avg. Volume (3 month) | 92 USD |
| Avg. Daily Volume (10-Days) | 60 USD |
| Shares Outstanding | 206.52M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 58.77% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 5:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | January 31, 2022 |
| Most Recent Quarter (mrq) | October 31, 2022 |
| Next Fiscal Year End | January 31, 2023 |
Profitability
| Profit Margin | 18.79% |
| Operating Margin (ttm) | 23.62% |
| Gross Margin | 40.75% |
| EBITDA Margin | 23.92% |
Management Effectiveness
| Return on Assets (ttm) | 40.97% |
| Return on Equity (ttm) | 84.15% |
Income Statement
| Revenue (ttm) | 4.98M USD |
| Revenue Per Share (ttm) | 0.02 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 2.06M USD |
| EBITDA | 1.19M USD |
| Net Income Avi to Common (ttm) | 935.61K USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 24.05K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 329.63K USD |
| Total Debt/Equity (mrq) | 19.61 USD |
| Current Ratio (mrq) | 4.328 |
| Book Value Per Share (mrq) | 0.008 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -240006 USD |
| Levered Free Cash Flow (ttm) | -481095 USD |
Profile of VitaSpring Biomedical
| Country | United States |
| State | CA |
| City | Irvine |
| Address | 400 Spectrum Center Drive |
| ZIP | 92618 |
| Phone | 949 202 9235 |
| Website | https://www.vitaspringbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
VitaSpring Biomedical Co. Ltd. focuses on the development of drugs of cell medicine. The company was formerly known as Shemn Corp. and changed its name to VitaSpring Biomedical Co. Ltd. in February 2020. VitaSpring Biomedical Co. Ltd. was incorporated in 2016 and is headquartered in Irvine, California.
Q&A For VitaSpring Biomedical Stock
What is a current VSBC stock price?
VitaSpring Biomedical VSBC stock price today per share is 1 USD.
How to purchase VitaSpring Biomedical stock?
You can buy VSBC shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for VitaSpring Biomedical?
The stock symbol or ticker of VitaSpring Biomedical is VSBC.
Which industry does the VitaSpring Biomedical company belong to?
The VitaSpring Biomedical industry is Biotechnology.
How many shares does VitaSpring Biomedical have in circulation?
The max supply of VitaSpring Biomedical shares is 3.1B.
What is VitaSpring Biomedical Price to Earnings Ratio (PE Ratio)?
VitaSpring Biomedical PE Ratio is now.
What was VitaSpring Biomedical earnings per share over the trailing 12 months (TTM)?
VitaSpring Biomedical EPS is 0 USD over the trailing 12 months.
Which sector does the VitaSpring Biomedical company belong to?
The VitaSpring Biomedical sector is Healthcare.